1. The prognostic value of the C-reactive protein to albumin ratio in cancer
   Xinhua Cui et al, 2020, Medicine CrossRef
2. A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy
   Mohammad A. I. Al-Hatamleh et al, 2019, Journal of Oncology CrossRef
3. Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer
   Qiang Fu et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
4. Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment
   Mohammad A. I. Al-Hatamleh et al, 2019, Cells CrossRef
5. Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis
   Ramy Gadalla et al, 2019, Breast Cancer Research and Treatment CrossRef
6. Targeting TNFR2 for cancer immunotherapy: recent advances and future directions
   Linxue Li et al, 2024, Journal of Translational Medicine CrossRef
7. The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
   Hiroyuki Takahashi et al, 2022, Cells CrossRef
8. Aberrant frequency of TNFR2-expressing CD4+ FoxP3+ regulatory T cells in nasopharyngeal carcinoma patients
   Engku Nur Syafirah Engku Abd Rahman et al, 2023, Cytokine CrossRef
9. TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
   Yuqiao Sheng et al, 2018, Frontiers in Immunology CrossRef
10. High expression of tumor necrosis factor receptor 2 in tissue is associated with progression and prognosis of esophageal squamous cell carcinoma
    Zifeng Liu et al, 2018, Human Pathology CrossRef
11. Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
    Muchun Li et al, 2022, Frontiers in Oncology CrossRef
12. Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy
    Juliane Medler et al, 2022, Cancers CrossRef
13. Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
    Steven F. Josephs et al, 2018, Journal of Translational Medicine CrossRef
14. Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation
    Jin-Hee Lee et al, 2024, Archives of Pharmacal Research CrossRef
15. LINC00173 silence and estrone supply suppress ER+ breast cancer by estrogen receptor α degradation and LITAF activation
    Yu Xie et al, 2024, Cancer Science CrossRef
16. The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches
    Daniel Cruceriu et al, 2020, Cellular Oncology CrossRef